Drug Enforcement Administration 2011 – Federal Register Recent Federal Regulation Documents

Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-33421
Type: Notice
Date: 2011-12-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-33404
Type: Notice
Date: 2011-12-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2011-33402
Type: Notice
Date: 2011-12-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-33400
Type: Notice
Date: 2011-12-29
Agency: Drug Enforcement Administration, Department of Justice
Barry M. Schultz, M.D.; Decision and Order
Document Number: 2011-32393
Type: Notice
Date: 2011-12-19
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V
Document Number: 2011-32172
Type: Rule
Date: 2011-12-15
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration (DEA) places the substance ezogabine, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule V of the Controlled Substances Act (CSA). This action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.
Controlled Substances: Established Aggregate Production Quotas for 2012
Document Number: 2011-32163
Type: Notice
Date: 2011-12-15
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes the initial 2012 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-32045
Type: Notice
Date: 2011-12-14
Agency: Drug Enforcement Administration, Department of Justice
Established Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2012
Document Number: 2011-31777
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes the initial 2012 assessment of annual needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-31776
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-31774
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Registration
Document Number: 2011-31773
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-31771
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-31768
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-31767
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2011-31766
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2011-31765
Type: Notice
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV
Document Number: 2011-31542
Type: Rule
Date: 2011-12-12
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration (DEA) places the substance carisoprodol, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA). This action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing. The decision of the Administrator is reprinted in its entirety below.
Controlled Substances: Final Adjusted Aggregate Production Quotas for 2011
Document Number: 2011-31621
Type: Notice
Date: 2011-12-09
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes final adjusted 2011 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Final Adjusted Assessment of Annual Needs for the List I Chemicals: Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2011
Document Number: 2011-31619
Type: Notice
Date: 2011-12-09
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes the Final Adjusted 2011 assessment of annual needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Implementation of the Methamphetamine Production Prevention Act of 2008
Document Number: 2011-30630
Type: Rule
Date: 2011-12-01
Agency: Drug Enforcement Administration, Department of Justice
In October 2008, the President signed the Methamphetamine Production Prevention Act of 2008 (MPPA), which clarifies the information entry and signature requirements for electronic logbook systems permitted for the retail sale of scheduled listed chemical products. On March 23, 2010, DEA published a Notice of Proposed Rulemaking to implement the provisions of the MPPA and make its regulations consistent with the new requirements. This action finalizes without change the Notice of Proposed Rulemaking published on March 23, 2010. The Final Rule will make it easier for regulated sellers to maintain electronic logbooks by allowing greater flexibility as to how information may be captured.
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-30695
Type: Notice
Date: 2011-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-30690
Type: Notice
Date: 2011-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-30689
Type: Notice
Date: 2011-11-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2011-30687
Type: Notice
Date: 2011-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-30685
Type: Notice
Date: 2011-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application
Document Number: 2011-30551
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Registration
Document Number: 2011-30550
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2011-30549
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application
Document Number: 2011-30547
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Registration
Document Number: 2011-30546
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application
Document Number: 2011-30544
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Registration
Document Number: 2011-30543
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-30542
Type: Notice
Date: 2011-11-28
Agency: Drug Enforcement Administration, Department of Justice
Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act
Document Number: 2011-30081
Type: Proposed Rule
Date: 2011-11-23
Agency: Drug Enforcement Administration, Department of Justice
This Notice of Proposed Rulemaking (NPRM) proposes to classify the following two steroids as ``anabolic steroids'' under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy- 5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3 -one). The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as Schedule III controlled substances subject to the regulatory control provisions of the CSA.
Kamal Tiwari, M.D.; Pain Management and Surgery Center of Southern Indiana; Decision and Order
Document Number: 2011-29708
Type: Notice
Date: 2011-11-18
Agency: Drug Enforcement Administration, Department of Justice
Scott D. Fedosky, M.D.; Denial of Application
Document Number: 2011-29722
Type: Notice
Date: 2011-11-17
Agency: Drug Enforcement Administration, Department of Justice
Robert G. Crummie, M.D.; Decision and Order
Document Number: 2011-29721
Type: Notice
Date: 2011-11-17
Agency: Drug Enforcement Administration, Department of Justice
Silviu Ziscovici, M.D.; Decision and Order
Document Number: 2011-29720
Type: Notice
Date: 2011-11-17
Agency: Drug Enforcement Administration, Department of Justice
James L. Hooper, M.D.; Decision and Order
Document Number: 2011-29709
Type: Notice
Date: 2011-11-17
Agency: Drug Enforcement Administration, Department of Justice
Joseph Giacchino, M.D.; Decision and Order
Document Number: 2011-29692
Type: Notice
Date: 2011-11-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2011-28013
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice
Aaron Gloskowski, D.O.; Decision and Order
Document Number: 2011-28011
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice
David T. Koon, M.D.; Revocation of Registration
Document Number: 2011-28010
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice
Linda Sue Cheek, M.D., Decision and Order
Document Number: 2011-28002
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice
Shawn M. Gallegos, D.D.S., Decision and Order
Document Number: 2011-27985
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice
Abelardo E. Lecompte-Torres, M.D. Decision and Order
Document Number: 2011-27929
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice
Treasure Coast Specialty Pharmacy Decision and Order
Document Number: 2011-27927
Type: Notice
Date: 2011-10-28
Agency: Drug Enforcement Administration, Department of Justice